Section a: patient information was requested but not provided.Manufacturer's investigation conclusion: review of the submitted photographs confirmed the report of foamy discharge within the lower orange housing of the device, indicative of leakage.It was reported that the oxygenator had been in use for a total of 4 hours and 15 minutes.After approximately 3 hours of use, there was blood leakage with post-oxygenator partial pressure of oxygen (pao2) measured at 311 millimeters of mercury (mmhg) and pre-oxygenator pao2 measured at 62 mmhg with hemoglobin of 6.1.Foaming was also noted.The oxygenator was exchanged for another manufacturer¿s device.The oxygenator was discarded and is not available for evaluation.It was reported that there were no adverse consequences to the patient.The eurosets amg pmp oxygenator, lot number 6183306, was not returned for investigation; therefore, a specific cause for the reported blood leak could not be conclusively determined through this evaluation.The production documentation for amg pmp oxygenator, lot number 6183306, was reviewed by the manufacturer (eurosets) and showed that all tests from the production process were compliant with the technical specifications.However, eurosets indicated that this type of leak could have resulted from damage to a fiber that occurred at some point following the manufacturing and testing phases.The eurosets amg pmp instructions for use (ifu) is currently available.Under the list of warnings, the ifu warns that during the extracorporeal circulation (ecc) a backup oxygenator is necessary and also warns that the extracorporeal circulation has to be carefully and continuously checked.Also under the list of warnings, the ifu warns that ¿before using the product it is advisable to carefully inspect it.Shipping and handling could cause structural and functional damage to the device.¿ the section "during bypass" warns that the act (activated coagulation time) must always be longer than or equal to 480 seconds in order to ensure adequate anticoagulation of the extracorporeal circuit.Under the section titled ¿oxygenator replacement¿, this document states that a spare oxygenator must always be available during perfusion.After 6 hours of use with blood or if particular situations occur, which may lead the person responsible for perfusion to determine the safety of the patient may be compromised (insufficient oxygenator performance, leaks, abnormal blood parameters, etc.), follow the procedure outlined in the ifu for oxygenator replacement.The production documentation for amg pmp oxygenator, lot number 6183306, was reviewed by the external manufacturer and showed that all tests from the production process were compliant with the technical specifications.No further information was provided.The manufacturer is closing the file on this event.
|